Skip to main content

Immunotherapy for Non-melanoma Skin Cancer



Immunotherapy for Non-melanoma Skin Cancer


Course Description
Immunotherapy for non-melanoma skin cancer" will use real-world cases to discuss the role of immunotherapy in the treatment of non-melanoma skin cancer. The webinar will include a summary of data for immunotherapy for non-melanoma skin cancers as well as a discussion of adverse events.

Learning Objectives

At the conclusion of this activity, participants should be able to:
  • Define non-melanoma skin cancers that oculd benefit from immunotherapy.
  • Summarize available immunotherapies for non-melanoma skin cancers.
  • Discuss outcomes and adverse events associated with immunotherapy for non-melanoma skin cancers.

Event Presenter(s)

Emily Ruiz, MD, MPH
Faculty

Dr. Ruiz is a board-certified dermatologist and the Director of the Mohs and Dermatologic Surgery Center, as well as the Director of Mohs Surgery at the VA Boston Healthcare System. She is also an Assistant Professor at Harvard Medical School.

Abigail Waldman, MD, MHS
Faculty

Dr. Waldman is a board-certified dermatologist and the Academic Director of the Mohs and Dermatologic Surgery Center, as well as the Director of the High-Risk Skin Cancer Clinic at the Dana-Farber Brigham Cancer Center. She is also an Assistant Professor at Hardvard medical School.

Duration
60 minutes

Credits
CME: 1.00 AMA PRA Category 1 Credit™

Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
Copyright 2022 American Society for Dermatologic Surgery (ASDS). All Rights Reserved.